Research programme: PPAR alpha/gamma agonists - Eli Lilly and Company
Alternative Names: LY 465608Latest Information Update: 11 Aug 2006
At a glance
- Originator Eli Lilly and Company
- Class
- Mechanism of Action Peroxisome proliferator-activated receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Type 2 diabetes mellitus